These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21693041)

  • 1. Potential utility of natural products as regulators of breast cancer-associated aromatase promoters.
    Khan SI; Zhao J; Khan IA; Walker LA; Dasmahapatra AK
    Reprod Biol Endocrinol; 2011 Jun; 9():91. PubMed ID: 21693041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of breast cancer-associated aromatase promoters.
    Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
    Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.
    Brueggemeier RW; Gu X; Mobley JA; Joomprabutra S; Bhat AS; Whetstone JL
    Ann N Y Acad Sci; 2001 Dec; 948():51-66. PubMed ID: 11795395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen production and action.
    Nelson LR; Bulun SE
    J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase in aging women.
    Bulun SE; Zeitoun K; Sasano H; Simpson ER
    Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression.
    Chen S; Ye J; Kijima I; Evans D
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11032-7. PubMed ID: 20534486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
    Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
    Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
    Brueggemeier RW; Díaz-Cruz ES
    Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors in the treatment of breast cancer.
    Brueggemeier RW; Hackett JC; Diaz-Cruz ES
    Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
    Miller WR
    Semin Oncol; 2003 Aug; 30(4 Suppl 14):3-11. PubMed ID: 14513432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on Natural Agents as Aromatase Inhibitors: Management of Breast Cancer.
    Singh S
    Comb Chem High Throughput Screen; 2024; 27(18):2623-2638. PubMed ID: 37861041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
    Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
    Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organization of the human aromatase p450 (CYP19) gene.
    Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
    Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
    Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
    van Meeuwen JA; Korthagen N; de Jong PC; Piersma AH; van den Berg M
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):372-83. PubMed ID: 17482226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of estrogen and their importance.
    Simpson ER
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.